STERIS ROE 2012-2025 | STE

Current and historical return on equity (ROE) values for STERIS (STE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
STERIS ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-09-30 $0.69B $7.02B 10.19%
2025-06-30 $0.65B $6.97B 9.72%
2025-03-31 $0.62B $6.62B 9.45%
2024-12-31 $0.47B $6.43B 7.28%
2024-09-30 $0.44B $6.61B 6.76%
2024-06-30 $0.40B $6.37B 6.32%
2024-03-31 $0.38B $6.32B 6.04%
2023-12-31 $0.57B $6.43B 9.12%
2023-09-30 $0.55B $6.19B 8.98%
2023-06-30 $0.12B $6.18B 1.99%
2023-03-31 $0.11B $6.09B 1.76%
2022-12-31 $-0.03B $6.05B -0.45%
2022-09-30 $-0.01B $5.81B -0.13%
2022-06-30 $0.38B $6.42B 5.77%
2022-03-31 $0.24B $6.55B 3.71%
2021-12-31 $0.28B $6.62B 4.72%
2021-09-30 $0.25B $6.55B 4.78%
2021-06-30 $0.29B $6.59B 6.35%
2021-03-31 $0.40B $3.89B 10.67%
2020-12-31 $0.43B $3.88B 12.02%
2020-09-30 $0.42B $3.66B 12.14%
2020-06-30 $0.41B $3.49B 12.20%
2020-03-31 $0.41B $3.42B 12.27%
2019-12-31 $0.39B $3.40B 12.03%
2019-09-30 $0.34B $3.24B 10.52%
2019-06-30 $0.32B $3.25B 10.04%
2019-03-31 $0.30B $3.19B 9.68%
2018-12-31 $0.27B $3.11B 8.57%
2018-09-30 $0.32B $3.13B 10.06%
2018-06-30 $0.30B $3.10B 9.72%
2018-03-31 $0.29B $3.22B 9.45%
2017-12-31 $0.24B $3.12B 8.16%
2017-09-30 $0.14B $3.04B 4.95%
2017-06-30 $0.12B $2.94B 4.13%
2017-03-31 $0.11B $2.81B 3.75%
2016-12-31 $0.14B $2.77B 4.75%
2016-09-30 $0.17B $3.01B 5.49%
2016-06-30 $0.14B $3.05B 5.31%
2016-03-31 $0.11B $3.04B 5.40%
2015-12-31 $0.09B $2.99B 6.01%
2015-09-30 $0.11B $1.09B 10.32%
2015-06-30 $0.13B $1.10B 12.41%
2015-03-31 $0.14B $1.07B 12.61%
2014-12-31 $0.13B $1.08B 12.51%
2014-09-30 $0.12B $1.07B 11.85%
2014-06-30 $0.12B $1.07B 11.98%
2014-03-31 $0.13B $1.04B 12.96%
2013-12-31 $0.13B $1.01B 13.47%
2013-09-30 $0.15B $0.99B 15.77%
2013-06-30 $0.16B $0.97B 17.31%
2013-03-31 $0.16B $0.95B 17.76%
2012-12-31 $0.16B $0.92B 18.74%
2012-09-30 $0.15B $0.88B 17.84%
2012-06-30 $0.14B $0.83B 17.18%
2012-03-31 $0.14B $0.82B 17.15%
2011-12-31 $0.13B $0.78B 16.70%
2011-09-30 $0.12B $0.78B 15.32%
2011-06-30 $0.13B $0.82B 16.33%
2011-03-31 $0.05B $0.79B 7.01%
2010-12-31 $0.04B $0.75B 5.87%
2010-09-30 $0.06B $0.73B 8.51%
2010-06-30 $0.06B $0.70B 7.77%
2010-03-31 $0.13B $0.75B 16.91%
2009-12-31 $0.13B $0.73B 16.84%
2009-09-30 $0.12B $0.80B 15.34%
2009-06-30 $0.11B $0.76B 15.23%
2009-03-31 $0.11B $0.72B 15.49%
2008-12-31 $0.11B $0.72B 15.28%
2008-09-30 $0.10B $0.75B 14.11%
2008-06-30 $0.09B $0.71B 12.23%
2008-03-31 $0.08B $0.71B 10.26%
2007-12-31 $0.08B $0.75B 10.55%
2007-09-30 $0.08B $0.77B 10.45%
2007-06-30 $0.08B $0.77B 10.63%
2007-03-31 $0.08B $0.77B 11.15%
2006-12-31 $0.06B $0.75B 8.28%
2006-09-30 $0.07B $0.72B 9.26%
2006-06-30 $0.07B $0.70B 9.19%
2006-03-31 $0.07B $0.73B 9.40%
2005-12-31 $0.09B $0.74B 11.62%
2005-09-30 $0.08B $0.74B 11.11%
2005-06-30 $0.09B $0.72B 11.69%
2005-03-31 $0.09B $0.76B 12.03%
2004-12-31 $0.09B $0.73B 13.07%
2004-09-30 $0.09B $0.70B 13.96%
2004-06-30 $0.10B $0.67B 14.62%
2004-03-31 $0.09B $0.68B 14.84%
2003-12-31 $0.09B $0.64B 15.03%
2003-09-30 $0.08B $0.61B 14.65%
2003-06-30 $0.08B $0.58B 14.90%
2003-03-31 $0.08B $0.57B 14.96%
2002-12-31 $0.07B $0.54B 13.99%
2002-09-30 $0.06B $0.51B 13.11%
2002-06-30 $0.06B $0.49B 11.68%
2002-03-31 $0.05B $0.49B 10.09%
2001-12-31 $0.01B $0.46B 2.27%
2001-09-30 $0.01B $0.45B 1.38%
2001-06-30 $0.00B $0.43B 0.93%
2001-03-31 $0.00B $0.42B 0.23%
2000-12-31 $-0.01B $0.44B -1.40%
2000-09-30 $-0.01B $0.43B -1.16%
2000-06-30 $0.00B $0.42B 0.46%
2000-03-31 $0.01B $0.42B 2.30%
1999-12-31 $0.06B $0.45B 14.39%
1999-09-30 $0.08B $0.44B 17.48%
1999-06-30 $0.08B $0.42B 19.16%
1999-03-31 $0.09B $0.44B 20.94%
1998-12-31 $0.08B $0.42B 19.65%
1998-09-30 $0.07B $0.40B 19.36%
1998-06-30 $0.07B $0.38B 19.18%
1998-03-31 $0.07B $0.36B 19.61%
1997-12-31 $0.06B $0.34B 19.33%
1997-09-30 $0.06B $0.33B 18.75%
1997-06-30 $0.05B $0.31B 18.77%
1997-03-31 $-0.03B $0.30B -11.09%
1996-12-31 $-0.04B $0.29B -19.79%
1996-09-30 $-0.05B $0.26B -34.42%
1996-06-30 $-0.06B $0.24B -56.59%
1996-03-31 $0.02B $0.06B 28.70%
1995-12-31 $0.02B $0.06B 29.13%
1995-09-30 $0.01B $0.05B 29.32%
1995-06-30 $0.01B $0.05B 20.45%
1995-03-31 $0.01B $0.05B 22.09%
1994-12-31 $0.01B $0.04B 20.92%
1994-09-30 $0.01B $0.04B 19.58%
1994-06-30 $0.01B $0.04B 17.78%
1994-03-31 $0.01B $0.04B 18.90%
1993-12-31 $0.01B $0.03B 16.81%
1993-09-30 $0.01B $0.03B 18.87%
1993-06-30 $0.00B $0.03B 17.20%
1993-03-31 $0.00B $0.03B 9.76%
1992-12-31 $0.00B $0.02B 13.33%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $25.505B $5.460B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $228.085B 27.10
Intuitive Surgical (ISRG) United States $201.399B 78.80
IDEXX Laboratories (IDXX) United States $57.017B 56.62
Edwards Lifesciences (EW) United States $48.652B 32.62
IQVIA Holdings (IQV) United States $41.139B 22.94
Alcon (ALC) Switzerland $38.961B 26.33
Mettler-Toledo (MTD) United States $30.332B 35.49
DexCom (DXCM) United States $27.399B 37.77
Waters (WAT) United States $23.464B 31.03
Coloplast (CLPBY) Denmark $20.125B 34.35
Hologic (HOLX) United States $16.689B 17.53
SONOVA HOLDING (SONVY) Switzerland $16.475B 0.00
Globus Medical (GMED) United States $12.067B 25.33
Penumbra (PEN) United States $11.787B 82.91
Masimo (MASI) United States $6.974B 22.35
Glaukos (GKOS) United States $6.331B 0.00
Sysmex ADR (SSMXY) Japan $6.289B 19.98
TransMedics (TMDX) United States $4.877B 57.78
Teleflex (TFX) United States $4.592B 7.32
Veracyte (VCYT) United States $3.403B 38.78
LivaNova (LIVN) United Kingdom $3.349B 18.09
Integer Holdings (ITGR) United States $2.899B 13.61
Alphatec Holdings (ATEC) United States $2.444B 0.00
Elekta AB (EKTAY) Sweden $2.366B 22.14
Nihon Kohden (NHNKY) Japan $2.034B 17.76
Artivion (AORT) United States $2.032B 93.26
UFP Technologies (UFPT) United States $1.947B 25.71
PROCEPT BioRobotics (PRCT) United States $1.709B 0.00
AxoGen (AXGN) United States $1.427B 0.00
Tandem Diabetes Care (TNDM) United States $1.417B 0.00
IRadimed (IRMD) United States $1.263B 60.15
OPKO Health (OPK) United States $1.029B 0.00
Integra LifeSciences Holdings (IART) United States $0.961B 5.21
Pulse Biosciences (PLSE) United States $0.959B 0.00
SiBone (SIBN) United States $0.776B 0.00
Beta Bionics (BBNX) United States $0.760B 0.00
Tactile Systems Technology (TCMD) United States $0.669B 38.90
Pacific Biosciences Of California (PACB) United States $0.643B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.586B 0.00
Alpha Tau Medical (DRTS) Israel $0.556B 0.00
NeuroPace (NPCE) United States $0.537B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.529B 10.56
OrthoPediatrics (KIDS) United States $0.469B 0.00
Mesa Laboratories (MLAB) United States $0.466B 12.86
RxSight (RXST) United States $0.416B 0.00
AngioDynamics (ANGO) United States $0.415B 0.00
ClearPoint Neuro (CLPT) United States $0.411B 0.00
Delcath Systems (DCTH) United States $0.368B 61.29
Sight Sciences (SGHT) United States $0.361B 0.00
Semler Scientific (SMLR) United States $0.311B 2.32
Spectral Diagnostics (EDTXF) Canada $0.310B 0.00
Nano-X Imaging (NNOX) Israel $0.199B 0.00
908 Devices (MASS) United States $0.194B 0.00
Anteris Technologies Global (AVR) Australia $0.185B 0.00
Treace Medical Concepts (TMCI) United States $0.173B 0.00
Inogen (INGN) United States $0.169B 0.00
Lucid Diagnostics (LUCD) United States $0.164B 0.00
CVRx (CVRX) United States $0.160B 0.00
EDAP TMS S.A (EDAP) France $0.153B 0.00
Zomedica (ZOMDF) United States $0.151B 0.00
Solana (HSDT) United States $0.142B 0.00
Microbot Medical (MBOT) United States $0.142B 0.00
LENSAR (LNSR) United States $0.140B 0.00
Rapid Micro Biosystems (RPID) United States $0.135B 0.00
Neuronetics (STIM) United States $0.123B 0.00
Hyperfine (HYPR) United States $0.111B 0.00
Accuray (ARAY) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.087B 0.00
Atossa Genetics (ATOS) United States $0.082B 0.00
DarioHealth (DRIO) United States $0.079B 0.00
QT Imaging Holdings (QTIH) United States $0.068B 0.00
InspireMD (NSPR) United States $0.067B 0.00
Positron (POSC) United States $0.057B 0.00
Spectral AI (MDAI) United States $0.049B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Envoy Medical (COCH) United States $0.020B 0.00
Vicarious Surgical (RBOT) United States $0.018B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
Adagio Medical Holdings (ADGM) United States $0.014B 0.00
Check-Cap (MBAI) Israel $0.012B 0.00
Tenon Medical (TNON) United States $0.011B 0.00
PAVmed (PAVM) United States $0.008B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 11.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00